(HealthDay)—Hypertension, elevated cholesterol, and hearing difficulty are more prevalent among noise-exposed workers, according to a study published online March 14 in the American Journal of Industrial Medicine.
Apr 12, 2018
0
8
An approach that could reduce the chances of drugs failing during the later stages of clinical trials has been demonstrated by a collaboration between the University of Cambridge and pharmaceutical company GlaxoSmithKline ...
Jun 1, 2016
0
53
(HealthDay)—Gliptin treatment is associated with increased acute pancreatitis risk, according to research published online Sept. 22 in Diabetes Care.
Sep 27, 2016
0
1
(AP)—Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure.
Aug 24, 2012
0
0
The drugmaker Merck is paying $830 million to resolve a federal class-action lawsuit involving shareholders and the painkiller Vioxx, which was pulled from the market years ago over safety concerns.
Jan 15, 2016
0
0
In patients with type 2 diabetes and acute coronary syndrome, the glucose-lowering medication lixisenatide did not increase or decrease the rate of cardiovascular (CV) events compared to placebo, according to results of the ...
Aug 31, 2015
0
10
State policies in eight different policy domains, including gun safety, labor and tobacco, are associated with U.S. working-age mortality, according to a new study published this week in the open-access journal PLOS ONE by ...
Oct 26, 2022
1
46
(HealthDay)—Movantik (naloxegol) has been approved by the U.S. Food and Drug Administration to treat opioid-induced constipation, the agency said Tuesday.
Sep 16, 2014
0
0
An international, multidisciplinary team including investigators from Brigham and Women's Hospital (BWH) has found that lixisenatide, a member of a class of glucose-lowering drugs frequently prescribed in Europe to patients ...
Jun 8, 2015
0
7
A 10-year trial involving osteoarthritis and rheumatoid arthritis patients in 13 countries reveals new insights on the cardiovascular safety of widely used nonsteroidal anti-inflammatory drugs and COX-2-specific inhibitors, ...
Nov 14, 2016
0
0
